News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

JADO Technologies Appoints New CEO


9/4/2007 6:46:52 AM

JADO Technologies, the leading developer of novel cell membrane-targeted drugs, today announced the appointment of Charl van Zyl as its new Chief Executive Officer. Charl van Zyl will take over from Dr. Gary Jennings, cofounder and former CEO/CSO, who will continue as Chief Scientific Officer.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES